{"entity":{"type":"insider","cik":"0001391382","url":"/insider/0001391382","json_url":"/insider/0001391382.json","name":"Terifay Robert J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":49,"n_filings":15,"first":"2011-02-16","last":"2017-06-19","span_basis":"filed_date"},"name_variants":[{"name":"Terifay Robert J","source":"filing","n_filings":15,"first_seen":"2011-02-16","last_seen":"2017-06-19"}],"transactions":[{"id":4251420,"accession":"0001708138-17-000007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001708138-17-000007","line_url":"/filing/0001708138-17-000007#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (EVP Commercial)","role_mark":"O","role_mark_label":"Officer (EVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21147.0,"shares_display":"21,147","price_per_share":468.19,"price_display":"468.19","price_state":"stated","total_value":9900813.93,"total_display":"9,900,813.93","total_whole":"9,900,814","shares_owned_after":23293.0,"shares_owned_after_display":"23,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-16","filed_date":"2017-06-19","scope":"insider"},{"id":8426047,"accession":"0001237899-15-000045","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001237899-15-000045","line_url":"/filing/0001237899-15-000045","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13423.0,"shares_display":"13,423","price_per_share":588.972765402667,"price_display":"588.97","price_state":"stated","total_value":7905781.43,"total_display":"7,905,781.43","total_whole":"7,905,781","shares_owned_after":27559.0,"shares_owned_after_display":"27,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-06","filed_date":"2015-08-07","scope":"insider","n_lines":8},{"id":8217575,"accession":"0001237899-15-000025","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001237899-15-000025","line_url":"/filing/0001237899-15-000025","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10993.0,"shares_display":"10,993","price_per_share":451.0057982352406,"price_display":"451.01","price_state":"stated","total_value":4957906.74,"total_display":"4,957,906.74","total_whole":"4,957,907","shares_owned_after":22129.0,"shares_owned_after_display":"22,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-17","filed_date":"2015-03-18","scope":"insider","n_lines":7},{"id":8870101,"accession":"0001237899-15-000020","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001237899-15-000020","line_url":"/filing/0001237899-15-000020#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11173.0,"shares_display":"11,173","price_per_share":423.67,"price_display":"423.67","price_state":"stated","total_value":4733664.91,"total_display":"4,733,664.91","total_whole":"4,733,665","shares_owned_after":20029.0,"shares_owned_after_display":"20,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-24","filed_date":"2015-02-25","scope":"insider"},{"id":7078093,"accession":"0001237899-14-000076","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001237899-14-000076","line_url":"/filing/0001237899-14-000076","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22362.0,"shares_display":"22,362","price_per_share":405.78660227171093,"price_display":"405.79","price_state":"stated","total_value":9074200.0,"total_display":"9,074,200.00","total_whole":"9,074,200","shares_owned_after":27749.0,"shares_owned_after_display":"27,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-19","scope":"insider","n_lines":9},{"id":6832464,"accession":"0001237899-14-000021","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001237899-14-000021","line_url":"/filing/0001237899-14-000021","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12865.0,"shares_display":"12,865","price_per_share":332.677234356782,"price_display":"332.68","price_state":"stated","total_value":4279892.62,"total_display":"4,279,892.62","total_whole":"4,279,893","shares_owned_after":22794.0,"shares_owned_after_display":"22,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-19","scope":"insider","n_lines":3},{"id":4490910,"accession":"0001237899-13-000032","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001237899-13-000032","line_url":"/filing/0001237899-13-000032","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8231.0,"shares_display":"8,231","price_per_share":261.2309707204471,"price_display":"261.23","price_state":"stated","total_value":2150192.12,"total_display":"2,150,192.12","total_whole":"2,150,192","shares_owned_after":15724.0,"shares_owned_after_display":"15,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-08","filed_date":"2013-05-09","scope":"insider","n_lines":3},{"id":2980800,"accession":"0001237899-12-000086","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001237899-12-000086","line_url":"/filing/0001237899-12-000086","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9745.0,"shares_display":"9,745","price_per_share":174.445361723961,"price_display":"174.45","price_state":"stated","total_value":1699970.05,"total_display":"1,699,970.05","total_whole":"1,699,970","shares_owned_after":11417.0,"shares_owned_after_display":"11,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-23","filed_date":"2012-11-26","scope":"insider","n_lines":3},{"id":3518417,"accession":"0001237899-12-000065","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001237899-12-000065","line_url":"/filing/0001237899-12-000065","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23834.0,"shares_display":"23,834","price_per_share":135.90648737098263,"price_display":"135.91","price_state":"stated","total_value":3239195.22,"total_display":"3,239,195.22","total_whole":"3,239,195","shares_owned_after":18306.0,"shares_owned_after_display":"18,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-30","filed_date":"2012-07-31","scope":"insider","n_lines":4},{"id":3518341,"accession":"0001237899-12-000017","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001237899-12-000017","line_url":"/filing/0001237899-12-000017","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9439.0,"shares_display":"9,439","price_per_share":90.58767454179468,"price_display":"90.59","price_state":"stated","total_value":855057.06,"total_display":"855,057.06","total_whole":"855,057","shares_owned_after":10272.0,"shares_owned_after_display":"10,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-01","filed_date":"2012-02-02","scope":"insider","n_lines":2},{"id":2980751,"accession":"0001237899-12-000013","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001237899-12-000013","line_url":"/filing/0001237899-12-000013#line-7","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9019.0,"shares_display":"9,019","price_per_share":74.2,"price_display":"74.20","price_state":"stated","total_value":669209.8,"total_display":"669,209.80","total_whole":"669,210","shares_owned_after":9372.0,"shares_owned_after_display":"9,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-11","filed_date":"2012-01-11","scope":"insider"},{"id":9124267,"accession":"0001237899-11-000064","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001237899-11-000064","line_url":"/filing/0001237899-11-000064","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7214.0,"shares_display":"7,214","price_per_share":65.31993900748544,"price_display":"65.32","price_state":"stated","total_value":471218.04,"total_display":"471,218.04","total_whole":"471,218","shares_owned_after":9372.0,"shares_owned_after_display":"9,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-11","filed_date":"2011-10-11","scope":"insider","n_lines":2},{"id":8968670,"accession":"0001237899-11-000024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001237899-11-000024","line_url":"/filing/0001237899-11-000024#line-2","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6099.0,"shares_display":"6,099","price_per_share":38.0,"price_display":"38.00","price_state":"stated","total_value":231762.0,"total_display":"231,762.00","total_whole":"231,762","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-04","filed_date":"2011-03-07","scope":"insider"},{"id":8979342,"accession":"0001237899-11-000023","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001237899-11-000023","line_url":"/filing/0001237899-11-000023","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48901.0,"shares_display":"48,901","price_per_share":38.0,"price_display":"38.00","price_state":"stated","total_value":1858238.0,"total_display":"1,858,238.00","total_whole":"1,858,238","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-17","filed_date":"2011-02-18","scope":"insider","n_lines":3},{"id":9105223,"accession":"0001237899-11-000021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001237899-11-000021","line_url":"/filing/0001237899-11-000021#line-2","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001391382","owner_name":"Terifay Robert J","owner_display_name":"Terifay Robert J","owner_url":"/insider/0001391382","role":"Officer (SVP Commercial)","role_mark":"O","role_mark_label":"Officer (SVP Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":37.02,"price_display":"37.02","price_state":"stated","total_value":185100.0,"total_display":"185,100.00","total_whole":"185,100","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-14","filed_date":"2011-02-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":49,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":49,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":49},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000872589","name":"REGENERON PHARMACEUTICALS INC","url":"/issuer/0000872589","role":"Officer (EVP Commercial)","n_filings":15,"first_seen":"2011-02-16","last_seen":"2017-06-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001391382","retrieved_at":"2026-08-23T11:17:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}